research Prevalence of Telogen Effluvium Hair Loss in COVID-19 Patients and Its Relationship with Disease Severity
COVID-19 patients may experience hair loss, but it's not linked to their age or sex.
Search
for
Sort by
Research
480-510 / 1000+ results 
research Mild-To-Moderate COVID-19 Is Not Associated With Worsening Of Alopecia Areata: A Retrospective Analysis Of 32 Patients
COVID-19 doesn't make alopecia areata worse.
research Recovery From Alopecia After COVID-19
A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.
research Hydroxychloroquine, Nitazoxanide, and Ivermectin Have Similar Effects in Early COVID-19: A Head-to-Head Comparison of the Pre-AndroCoV Trial
Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.
research Association Between Hair Diseases and COVID-19 Pandemic-Related Stress: A Cross-Sectional Study Analysis
The study suggests pandemic stress might worsen or trigger hair loss problems.
research A Comment on Psychological Distress and Women’s Hair Loss Related to the COVID-19 Pandemic
The COVID-19 pandemic has increased hair loss and psychological distress in women.
research Impact of the COVID-19 Pandemic on Tertiary Care University Dermatology Outpatient Clinic and Dermatology Procedures
The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.
research Telogen Effluvium in Patients Recovering from COVID-19
Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.
research A Systematic Review and Quality Evaluation of Studies on Long-Term Sequelae of COVID-19
COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.
research Reporting Cases of Telogen Effluvium as a Sequelae of COVID-19 Infection
COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.
research Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings After Recovery From COVID-19
More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.
research COVID-19 Induced Telogen Effluvium
COVID-19 may cause temporary hair loss in some people.
research Telogen Effluvium in the New SARS-CoV-2 Era
COVID-19 and related stress may increase hair loss known as Telogen effluvium.
research Intermittent Chronic Telogen Effluvium With an Unusual Dermoscopic Finding Following COVID-19
A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.
research Long COVID? What Is That?
Long COVID is a serious, long-lasting illness that needs more recognition and support.
research Risk Factors and Early Preventive Measures for Long COVID in Non-Hospitalized Patients: Analysis of a Large Cohort in the United Arab Emirates
Vaccination and timely treatment reduce the risk of long COVID.
research Telogen Effluvium in SARS-CoV-2 Infection: Histological Aspects
COVID-19 can cause a temporary hair loss condition.
research Prevalence and Clinical Characteristics of Androgenetic Alopecia in Nepalese Patients: A Cross-Sectional Observational Study
Androgenetic alopecia in Nepalese men often starts around age 29, with a possible link to COVID-19 worsening the condition.
research Telogen Effluvium as a Symptom of Long Covid in Pre-Infected SARS-CoV-2 Patients: An Integrative Literature Review
Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.
research Examining Alopecia Through Selected Case Studies in Bangladesh
The pandemic stress may have increased alopecia cases in Bangladesh.
research Journal of Cosmetic Dermatology — Editorial Commentary, May 2021
The May 2021 issue of the Journal of Cosmetic Dermatology suggests injectables are becoming more reliable and may reduce the need for cosmetic surgery.
research A Study of the Clinical Patterns of Hair Loss in Female Patients
Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.
research Vacuum Therapy with Plant Active Compounds, Prebiotics, and Probiotics for Androgenetic Alopecia, Female Pattern Hair Loss, and Telogen Effluvium: Follow-up Study
The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.
research Prevalence of Skin Diseases Among Hostellers Attending the Tertiary Care Hospital
Proper hygiene, adequate sleep, and self-care can reduce common skin diseases.
research 58-Year-Old Female with Diffuse Thinning of the Hair
Stress can cause temporary hair loss, which usually gets better after the stress is gone.
research Prescribing Patterns Amongst UK Dermatologists for the Treatment of Alopecia Areata, Female Pattern Hair Loss, and Frontal Fibrosing Alopecia
UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.
research Rosemary Oil vs Minoxidil 2% for the Treatment of Androgenetic Alopecia: A Randomized Comparative Trial
Rosemary oil and minoxidil 2% both effectively increase hair count in people with androgenetic alopecia, but rosemary oil causes less scalp itching.
research Evolution and Trends of Facial Plastic Surgery and Facial Aesthetic Procedures in India: From Awakening to Revival
Facial plastic surgeries and aesthetic procedures are becoming more popular in India, with a preference for non-surgical options and effective treatments for facial enhancement and hair loss.
research COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings
Many COVID-19 patients still have symptoms like fatigue and loss of taste or smell a month after diagnosis.
research Post-Discharge Persistent Symptoms and Health-Related Quality of Life After Hospitalization for COVID-19
Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.